IMR Press / JMCM / Volume 2 / Issue 3
Volume 2 Issue 3 2019
Order by
NULL
Open Access Original Research
Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers
Narayanan Silpa, Teng Qiu-Xu, Koya Jagadish, Wang Jingquan, ... Chen Zhe-Sheng
J. Mol. Clin. Med. 2019, 2(3), 55–67; https://doi.org/10.31083/j.jmcm.2019.03.0303
23
Download
1
Citations
63
Views
Open Access Original Research
KIT and PDGFRA inhibitor avapritinib (BLU-285) overcomes ABCB1- and ABCBG2-mediated MDR in cancer cells
Gupta Pranav, V. Ashar Yunali, Teng Qiu-Xu, Lei Zining, ... Chen Zhe-Sheng
J. Mol. Clin. Med. 2019, 2(3), 69–78; https://doi.org/10.31083/j.jmcm.2019.03.0301
8
Download
39
Views
Open Access Original Research
Immunotherapy in pediatric brain tumors: considerations, challenges and future directions
S. Kruithof Eline, van der Lugt Jasper, Hulleman Esther
J. Mol. Clin. Med. 2019, 2(3), 79–91; https://doi.org/10.31083/j.jmcm.2019.03.0302
5
Download
28
Views
Open Access Original Research
The use of biological glue (Starsil® Hemostat) in robotic partial nephrectomy: a safety and efficacy study
Zisman Ariel, Nativ Omri, Malshy Kamil, Sadeh Omer, ... E. Amiel Gilad
J. Mol. Clin. Med. 2019, 2(3), 93–96; https://doi.org/10.31083/j.jmcm.2019.03.0213
11
Download
77
Views
Back to top